JAK1 PATHWAY INHIBITORS FOR THE TREATMENT OF CHRONIC LUNG ALLOGRAFT DYSFUNCTION
- 专利权人:
- Incyte Corporation
- 发明人:
- Richard L. Schaub,Kevin O,Hayer
- 申请号：
- US16810045
- 公开号：
- US20200281931A1
- 申请日:
- 2020.03.05
- 申请国别(地区):
- US
- 年份:
- 2020
- 代理人:
- 摘要：
- This disclosure relates to JAK1 pathway inhibitors and the use thereof in treating chronic lung allograft dysfunction such as, e.g., bronchiolitis obliterans syndrome.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- INDUCTION OF TOLERANCE IN LUNG ALLOGRAFT TRANSPLANTATION
- INDUCTION OF TOLERANCE IN LUNG ALLOGRAFT TRANSPLANTATION
- ANTICORPS ANTI-CD20 DE TYPE II DESTINE A UNE UTILISATION DANS LA TRANSPLANTATION D'ORGANES
- TYPE II ANTI-CD20 ANTIBODY FOR USE IN ORGAN TRANSPLANTATION
- GLP-1 RECEPTOR AGONISTS FOR ISLET CELL TRANSPLANTATION
